eHealth Weight Loss Program in African American Breast Cancer Survivors

Completed · Not applicable

Conditions studied: Cancer Survivor, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage 0 Breast Cancer

In brief

This randomized pilot clinical trial studies how well a virtual weight loss program (SparkPeople) works in helping female African American breast cancer survivors maintain a healthy weight. Many patients with breast cancer are overweight or gain weight after diagnosis. SparkPeople is a free web-based weight loss program that features educational and motivational articles and videos, self-monitoring tools, incentives, social support communities (including discussion forums, teams, challenges, and expert blogs), and options for content to be delivered to members' email. It is a comprehensive program that includes advice on diet, physical activity, and behavioral strategies (such as self-monitoring diet and exercise), and emphasizes safe weight loss and receiving medical attention regularly when needed. A web-based program such as SparkPeople may help breast cancer survivors maintain a healthy weight, which may reduce the risk of cancer returning and patient fatigue, and improve patient quality of life.

Key facts

Study ID

NCT02699983

Run by

Rutgers, The State University of New Jersey

People needed

35

Starts

2016-01-08

Expected to finish

2018-07-29

Last updated by the study team

2021-04-13

Who can join

Age: 21 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have evidence of histologically confirmed breast cancer, stage 0, I, II or III, and be at least 2 years post diagnosis
• Patient is self-identified as African-American
• Patient is overweight or obese (body mass index [BMI] >= 25 kg/m\^2)
• Patient is able to understand and read English
• Patient must have home internet or smartphone access
• Patient must give informed consent for this new study

You may not qualify if…

• Patient has a serious medical condition (e.g., stroke, liver or renal failure, congestive heart failure, myocardial infarction or cardiac surgery in past year, angina pectoris) that would compromise the safety of the patient or compromise the patient's ability to complete the study, at the discretion of the investigator
• Patient has serious psychiatric condition (e.g., bipolar disorder, schizophrenia or other psychosis, bulimia or anorexia nervosa, suicide attempt within 6 months or current active suicidal ideation) that would compromise the patient's ability to complete the study, at the discretion of the investigator
• Patient has severe disabilities limiting moderate physical activity, such as severe orthopedic conditions
• Patient is planning major surgery within the next 6 months
• Patient is taking medications or supplements for weight loss currently or within the past 3 months
• Patient has successfully lost 5% of body weight in the previous 6 months or has had bariatric surgery
• Patient is pregnant, breastfeeding, has given birth within the last 3 months or planning pregnancy within the next 12 months; if participant becomes pregnant during the course of the study, she will be removed from further participation
• Patient is anticipating leaving the area within the next 12 months

Where it is running

• Rutgers Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.